AstraZeneca (AZN) Tops Q2 EPS by 14c
Tweet
Share
E-mail
Get Alerts AZN Hot Sheet
Join SI Premium – FREE
AstraZeneca (NASDAQ: AZN) reported Q2 EPS of $2.63, $0.14 better than the analyst estimate of $2.49. Revenue for the quarter came in at $15.38 billion versus the consensus estimate of $15.47 billion.
For earnings history and earnings-related data on AstraZeneca (AZN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freedom Broker Upgrades Core Scientific Inc. (CORZ) to Buy
- Deepseek Is Developing Massive Ai Data Center In Inner Mongolia - Bloomberg
- Inno Holdings stock set to resume trading on Nasdaq after halt
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
